We have previously demonstrated that the systemic transfer of the human delta-sarcoglycan cDNA, by using a combination of AAV vectors [35], brings to the rescue of the BIO14.6 cardiomyopathy and muscular dystrophy. The gene discussed is SGCD; the disease is cardiomyopathy.